Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain. 2015

Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
High Pressure Protein Research Center, Institute of Advanced Technology, Kinki University, 930 Nishimitani, Kinokawa, Wakayama 649-6493, Japan; Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Electronic address: sakurai@waka.kindai.ac.jp.

Recombinant human monoclonal antibodies have become important protein-based therapeutics for the treatment of various diseases. An IgG1 molecule, which is now mainly used for antibody preparation, consists of a total of 12 immunoglobulin domains. Each domain has one disulfide bond. The CH3 domain is the C-terminal domain of the heavy chain of IgG1. The disulfide bonds of some of the CH3 domains are known to be reduced in recombinant human monoclonal antibodies. The lack of intramolecular disulfide bonds may decrease the stability and increase the aggregation propensity of an antibody molecule. To investigate the effects of a reduced disulfide bond in the CH3 domain on conformational stability and aggregation propensity, we performed several physicochemical measurements including circular dichroism, differential scanning calorimetry (DSC), and 2D NMR. DSC measurements showed that both the stability and reversibility of the reduced form were lower than those of the oxidized form. In addition, detailed analyses of the thermal denaturation data revealed that, although a dominant fraction of the reduced form retained a stable dimeric structure, some fractions assumed a less-specifically associated oligomeric state between monomers. The results of the present study revealed the characteristic aggregation properties of antibody molecules.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010843 Pichia Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES isolated from exuded tree sap. Hansenula,Hansenulas,Pichias
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
January 2008, Protein science : a publication of the Protein Society,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
September 1982, Proceedings of the National Academy of Sciences of the United States of America,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
February 2022, Protein expression and purification,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
November 1988, Molecular immunology,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
December 2004, Proceedings of the National Academy of Sciences of the United States of America,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
January 2020, mAbs,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
October 2012, Journal of molecular biology,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
January 2009, Molecular pharmaceutics,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
April 2016, Biochemistry,
Kazumasa Sakurai, and Ryosuke Nakahata, and Young-Ho Lee, and József Kardos, and Takahisa Ikegami, and Yuji Goto
September 1972, Angewandte Chemie (International ed. in English),
Copied contents to your clipboard!